» Articles » PMID: 18202152

Aldosterone Regulates Rapid Trafficking of Epithelial Sodium Channel Subunits in Renal Cortical Collecting Duct Cells Via Protein Kinase D Activation

Overview
Journal Mol Endocrinol
Date 2008 Jan 19
PMID 18202152
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Aldosterone elicits rapid physiological responses in target tissues such as the distal nephron through the stimulation of cell signaling cascades. We identified protein kinase D (PKD1) as an early signaling response to aldosterone treatment in the M1-cortical collecting duct (M1-CCD) cell line. PKD1 activation was blocked by the PKC inhibitor chelerythrine chloride and by rottlerin, a specific inhibitor of PKCdelta. The activation of PKCdelta and PKCepsilon coincided with PKD1 activation and while a complex was formed between PKD1 and PKCepsilon after aldosterone treatment, there was a concurrent reduction in PKD1 association with PKCdelta. A stable PKD1 knockdown M1-CCD-derrived clone was developed in which PKD1 expression was 90% suppressed by gene silencing with a PKD1-specific siRNA. The effect of aldosterone treatment on the subcellular distribution of enhanced cyan fluorescent protein (eCFP)-tagged epithelial sodium channel (ENaC) subunits in wild type (WT) and PKD1 suppressed cells was examined using confocal microscopy. In an untreated confluent monolayer of M1-CCD cells, alpha, beta, and gamma ENaC subunits were evenly distributed throughout the cytoplasm of WT and PKD1-suppressed cells. After 2 min treatment, aldosterone stimulated the localization of each of the ENaC subunits to discrete regions within the cytoplasm of WT cells. The translocation of eCFP-ENaC subunits in WT cells was inhibited by rottlerin and the mineralocorticoid receptor (MR) antagonist spironolactone. No subcellular translocation of eCFP-ENaC subunits was observed in PKD1-suppressed cells treated with aldosterone. These data demonstrate the involvement of a novel MR/PKCdelta /PKD1 signaling cascade in the earliest ENaC subunit intracellular trafficking events that follow aldosterone treatment.

Citing Articles

Aldosterone: Renal Action and Physiological Effects.

Johnston J, Welch A, Cain B, Sayeski P, Gumz M, Wingo C Compr Physiol. 2023; 13(2):4409-4491.

PMID: 36994769 PMC: 11472823. DOI: 10.1002/cphy.c190043.


Cardiovascular Disease in Obstructive Sleep Apnea: Putative Contributions of Mineralocorticoid Receptors.

Badran M, Bender S, Gozal D Int J Mol Sci. 2023; 24(3).

PMID: 36768567 PMC: 9916750. DOI: 10.3390/ijms24032245.


Amiloride Improves Endothelial Function and Reduces Vascular Stiffness in Female Mice Fed a Western Diet.

Martinez-Lemus L, Aroor A, Ramirez-Perez F, Jia G, Habibi J, Demarco V Front Physiol. 2017; 8:456.

PMID: 28713285 PMC: 5492307. DOI: 10.3389/fphys.2017.00456.


Aldosterone Upregulates Transient Receptor Potential Melastatin 7 (TRPM7).

Valinsky W, Jolly A, Miquel P, Touyz R, Shrier A J Biol Chem. 2016; 291(38):20163-72.

PMID: 27466368 PMC: 5025699. DOI: 10.1074/jbc.M116.735175.


Cooperative Role of Mineralocorticoid Receptor and Caveolin-1 in Regulating the Vascular Response to Low Nitric Oxide-High Angiotensin II-Induced Cardiovascular Injury.

Pojoga L, Yao T, Opsasnick L, Siddiqui W, Reslan O, Adler G J Pharmacol Exp Ther. 2015; 355(1):32-47.

PMID: 26183312 PMC: 4576669. DOI: 10.1124/jpet.115.226043.


References
1.
Hanks S . Genomic analysis of the eukaryotic protein kinase superfamily: a perspective. Genome Biol. 2003; 4(5):111. PMC: 156577. DOI: 10.1186/gb-2003-4-5-111. View

2.
Ronzaud C, Loffing J, Bleich M, Gretz N, Grone H, Schutz G . Impairment of sodium balance in mice deficient in renal principal cell mineralocorticoid receptor. J Am Soc Nephrol. 2007; 18(6):1679-87. DOI: 10.1681/ASN.2006090975. View

3.
Zhou Z, Bubien J . Nongenomic regulation of ENaC by aldosterone. Am J Physiol Cell Physiol. 2001; 281(4):C1118-30. DOI: 10.1152/ajpcell.2001.281.4.C1118. View

4.
Pochynyuk O, Tong Q, Staruschenko A, Stockand J . Binding and direct activation of the epithelial Na+ channel (ENaC) by phosphatidylinositides. J Physiol. 2007; 580(Pt. 2):365-72. PMC: 2075560. DOI: 10.1113/jphysiol.2006.127449. View

5.
Storz P, Toker A . Protein kinase D mediates a stress-induced NF-kappaB activation and survival pathway. EMBO J. 2002; 22(1):109-20. PMC: 140053. DOI: 10.1093/emboj/cdg009. View